Clinical trial

Alzheimer's Disease Neuroimaging Initiative 4

NCT05617014

StatusENROLLING_BY_INVITATION

Study typeOBSERVATIONAL

Start date2023-06-09

PhaseN/A

Study timeline

Study start (actual)2023-06-09Date precision: day

Registry last updated2026-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer Diseaseunresolved

Dementiaunresolved

Interventions

NeuraceqRADIATION

AmyvidRADIATION

TauvidRADIATION

MK-6240RADIATION

NAV4694RADIATION

PI-2620RADIATION

Sponsors & collaborators

University of Southern Californialead sponsor

Northern California Institute of Research and Educationcollaborator

National Institute on Aging (NIA)collaborator

Alzheimer's Therapeutic Research Institutecollaborator

Mapped research locations

New YorkNew York, United States4 BostonMassachusetts, United States4 ChicagoIllinois, United States4 Los AngelesCalifornia, United States2 Washington D.C.District of Columbia, United States2 PhoenixArizona, United States2 ProvidenceRhode Island, United States2 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1 St LouisMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05617014 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.